Clinical outcomes and significant factors in the survival rate after decompression surgery for patients who were non-ambulatory due to spinal metastases

• Published in: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association Vol. 24; no. 2; pp. 347 - 352
• Main Authors: Tateiwa, Daisuke, Oshima, Kazuya, Nakai, Takaaki, Imura, Yoshinori, Tanaka, Takaaki, Outani, Hidetatsu, Tamiya, Hironari, Araki, Nobuhito, Naka, Norifumi
• Format: Journal Article
• Language: English
• Published: Japan Elsevier B.V 01.03.2019
• Subjects: Adult; Aged; Chemotherapy, Adjuvant; Cohort Studies; Decompression, Surgical - methods; Decompression, Surgical - mortality; Disability Evaluation; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Care - methods; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Spinal Cord Compression - diagnostic imaging; Spinal Cord Compression - etiology; Spinal Cord Compression - surgery; Spinal Cord Neoplasms - mortality; Spinal Cord Neoplasms - secondary; Spinal Cord Neoplasms - surgery; Survival Rate; Time Factors; Treatment Outcome; Walking
• ISSN: 0949-2658; 1436-2023
• DOI: 10.1016/j.jos.2018.10.003

The development of effective chemotherapy regimens and molecular targeting agents are improving the overall survival rates in patients with cancer. However, patients who are non-ambulatory due to metastatic epidural spinal cord compression (MESCC) may be assessed as unable to tolerate chemotherapy secondary to poor performance status. This means that the ambulatory status of patients with cancer might be significant for survival time. We investigated the functional outcomes and factors influencing overall survival in 31 patients who were non-ambulatory due to MESCC and underwent decompression surgery. The functional outcome was determined by the Frankel grading system. Twenty-one patients (68%) improved by at least 1 Frankel grade; 17 patients (55%) became ambulatory postoperatively. Most of postoperatively ambulatory patients could undergo postoperative chemotherapy (14/17, 82%). On the other hand, only a few postoperatively non-ambulatory patients could undergo postoperative chemotherapy (2/15, 13%). We observed a complication rate of 35.5% with specific complications including wound infection, pneumonia, and deep vein thrombosis/pulmonary embolus. The median survival duration was 7.0 months. Factors that significantly affected the overall survival in univariate analyses were revised Tokuhashi score (RTS) ≥ 4, postoperative chemotherapy, ambulatory status, and complications (RTS ≥ 4, P < 0.05; postoperative chemotherapy, P < 0.001; ambulatory status, P < 0.001; complications, P < 0.01). Decompression surgery for patients who are non-ambulatory due to MESCC directly contributes to functional outcomes and may indirectly contribute to overall survival. If non-ambulatory patients who are assessed as unable to tolerate chemotherapy due to poor performance status regain the ability to walk by decompression surgery, they will have a chance to receive postoperative chemotherapy, thereby increasing their chances of prolonging survival. However, postoperative complications may shorten their survival; therefore, we should carefully consider the surgical indications. RTS is useful for judging the surgical indication.